FDA Budget: Compounding Increase Paid With Construction Funding, Efficiencies
This article was originally published in The Pink Sheet Daily
Some planned buildings on the White Oak campus for FY 2015 would not be funded and savings from program efficiencies would create the $25 million in new funding for compounding oversight, Hamburg tells House committee.
You may also be interested in...
An omnibus spending agreement gives FDA about a 1.3% increase from its fiscal 2014 appropriation. CFSAN’s allocation of $903.4 million represents a more than 2% increase over fiscal 2014 enacted funding, consistent with the President’s budget request and the Senate’s proposed funding, but roughly $10 million less than the original House figure.
President Obama’s budget requests less headquarters consolidation funding in FY 2015 as CBER announces it will move staff to the campus between May and July.
The mandates in the FDA Safety and Innovation Act and Drug Quality and Security Act show a lot of congressional confidence in the agency, but FDA commissioner says that members also must provide resources to go with it.